IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04797832
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04797832
-
- Other papers using this trial's data
- The effect of intravenous sodium ferric gluconate complex (Ferrlecit) on outcomes of patients undergoing transcatheter aortic valve implantation: a prospective randomized controlled trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT04797832. Randomized; single masking; primary purpose treatment. Start 2020-10-18 (actual); primary completion 2024-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI
- Condition
- Iron Deficiency Anemia Due to Blood Loss
- Condition
- Aortic Stenosis
- Intervention (Drug)
- IV Sodium Ferric Gluconate Complex
- Lead sponsor
- Rambam Health Care Campus
Record details
- Record id
cardio:ct-nct04797832- Content hash
863d3779dacaa1c992d518920fa47002d8e4da8f18a162558d7439938751da50